| # | Drug | Count |
|---|---|---|
| 0 | ENOXAPARIN SODIUM | 166 |
| 1 | RIVAROXABAN | 138 |
| 2 | ASPIRIN | 111 |
| 3 | WARFARIN | 111 |
| 4 | CLOPIDOGREL | 105 |
| 5 | CLOPIDOGREL BISULFATE | 105 |
| 6 | ASPIRIN 325 MG | 104 |
| 7 | ASPIRIN 81 MG | 104 |
| 8 | FUROSEMIDE | 97 |
| 9 | BISOPROLOL FUMARATE | 93 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONCIZUMAB | 3 | 0.0667 |
| 1 | COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED | 1 | 0.0147 |
| 2 | MENADIONE | 1 | 0.0072 |
| 3 | NICARDIPINE HYDROCHLORIDE | 15 | 0.0067 |
| 4 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 5 | TROPICAMIDE | 7 | 0.0043 |
| 6 | PINDOLOL | 3 | 0.0037 |
| 7 | NICARDIPINE | 16 | 0.0036 |
| 8 | DIMETICONE | 1 | 0.0035 |
| 9 | LIFILEUCEL | 1 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 201 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 163 |
| 2 | Corticosteroid [EPC] | 149 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 111 |
| 4 | Loop Diuretic [EPC] | 104 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 98 |
| 6 | Proton Pump Inhibitor [EPC] | 79 |
| 7 | beta-Adrenergic Blocker [EPC] | 58 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 49 |
| 9 | Insulin Analog [EPC] | 47 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 3 | 0.0667 |
| 1 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 2 | Vitamin K [EPC] | 9 | 0.0010 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 13 | 0.0010 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 98 | 0.0008 |
| 6 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 7 | Factor Xa Inhibitor [EPC] | 201 | 0.0007 |
| 8 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 9 | Glinide [EPC] | 5 | 0.0006 |